PMID,Title,Journal,Year
40830314,Glucagon-Like Peptide-1 Receptor Agonist Therapy Does Not Increase Gastrointestinal Adverse Events in Patients with Inflammatory Bowel Disease.,Digestive diseases and sciences,2025
39516435,Efficacy and Safety of GLP-1 Agonists on Metabolic Parameters in Non-diabetic Patients with Inflammatory Bowel Disease.,Digestive diseases and sciences,2024
38767015,Effectiveness and safety of a GLP-1 agonist in obese patients with inflammatory bowel disease.,Revista espanola de enfermedades digestivas,2024
